Qnovia Launches Phase 1 Study for Innovative Nicotine Inhaler Targeting Smoking Cessation Qnovia, Inc. has initiated its Phase 1 clinical trial for the RespiRx™ Nicotine Inhaler, a groundbreaking approach to smoking cessation in the U.S.

Qnovia Launches Phase 1 Study for Innovative Nicotine Inhaler Targeting Smoking Cessation #USA #Richmond #Smoking_Cessation #Qnovia #RespiRx_Nicotine